Providing Global Market Intelligence

Ronin Corporation Logo




News

RONIN Extends Its Medical Panel to Latin America

12 Country Research Program shows some glimmers of Economic Recovery but highlights a slow return to spending on Information Techology

Improving completion rates and response accuracy with graphical, interactive questions
Click here to view the Webinar on Question Types

Psyma International, in cooperation with RONIN, presented Left-Brain vs. Right-Brain Prescribing: Uncovering Brand Potential at the PBIRG conference in Phoenix.

Bob Harlow speaks at ESOMAR's Panel Research conference

Quantitative Naming, Value Proposition and Message Testing Methodology developed

RONIN quality reaffirmed through two ISO certifications

 

Press Release

FOR IMMEDIATE RELEASE

Contact: Anton Richter
Tel. 020 7091 1400
Email: anton.richter@ronin.com

RONIN Extends Its Medical Panel to Latin America

RONIN has announced the expansion of its medical panel to Latin America. This panel is unique in that it was recruited entirely by phone to ensure the highest quality panelists. In keeping with this practice RONIN undertakes all panel development from its centralized call center in London, England. Using native speakers, hospital switchboards and physician offices are called to reach specialists and invite them to join the panel. “No one else in the industry has devoted this much attention to tracking down medical professionals and speaking to them as part of the panel recruitment process,” said Volker Balk, General Manager of RONIN’s London operation.

Anton Richter, Director of Business Development added “ Latin America represents a significant growth opportunity for pharmaceutical companies who are conducting research in all of the major Latin American countries. As we received an increasingly large number of requests from our market research partners to support this need, we made the investments to build out the panel in all major countries. It has become a significant, new business for us.”

The panel was recently used by RONIN itself as part of its Medical Pulse Program. Medical professionals from Argentina, Brazil, Chile, Columbia, Mexico and Venezuela participated in that quarterly tracking study.

 

 

Press Release

FOR IMMEDIATE RELEASE

Contact: Harry Bunn
Tel. (609) 452 8320
Email: harry.bunn@ronin.com

12 Country Research Program shows some glimmers of Economic Recovery but highlights a slow return to spending on Information Technology  

In the fifth wave of an ongoing study of the impact of the recession on companies and their use of Information Technology, RONIN found that there has been some positive change since Wave 4 was conducted in February. From early in 2009, a constant 48% of companies worldwide had been “strongly” or “extremely” negatively impacted and for the first time, this has decreased to 43%.

The study also found that companies have shown different behavior during the recession than prior to it …and these behavior changes are expected to continue when the recession is finally over. This “recessional realignment” has included an increased customer power that buyers have been able to exert during the recession which is coupled with a belief that the “recession pricing” that many vendors adopted during the recession to make some (albeit lower) margins rather than none will be continued going forward. There has also been a shift to more flexibility and variability with fixed cost structures are being replaced by variable cost structures. The cycle times for planning, budgets and projects have been decreased - the five year plan is a thing of the past. Complex, integrated, five year projects are being replaced by shorter, multi-phase projects with interim payback as each phase is completed. And risk avoidance has been evident throughout encouraging companies to buy well proven products from well established vendors.

The companies themselves are also splitting into two fundamentally different types in terms of the way they are reacting to the recession. About half are taking short term actions concentrating on cost cutting and leaving strategic aspects until they emerge from the recession, (“short termers”). The other half are taking advantage of the recession to re-think their business models and develop strategies which will allow them to emerge stronger (“strategics”). The “strategics” are embracing technology more and are implementing initiatives to expand their systems and infrastructure to help them emerge with competitive advantage over the “short termers”. They believe they will emerge stronger whereas the “short termers” believe they will not.

Harry Bunn, President and CEO of RONIN summed it up “We can see glimmers of light at the end of the tunnel for the first time in 18 months”

RONIN conducted this fifth phase of the ongoing program in late May, 2010. Over 7,600 surveys were completed over the five waves across 12 countries – US, Canada, Mexico, Brazil, Germany, UK, France, Italy, Spain, China, Japan, and Australia. Respondents were members of RONIN global IT Decision-Maker Panel.

RONIN Corporation is a global market research and marketing consulting firm with offices in Princeton NJ and London , England .

If you would like more information about this topic, or to schedule an interview with Harry Bunn, please call Jennie Koval at (609) 452-0060 or email Jennie at jennie.koval@ronin.com.

Psyma International, in cooperation with RONIN, presented Left-Brain vs. Right-Brain Prescribing: Uncovering Brand Potential at the PBIRG conference in Phoenix.
The presentation explored the role of emotions in physician prescribing behavior and reported on treatment patterns for bipolar disorder among psychiatrists and primary care physicians in the US, UK and Italy. The RONIN Medical Specialist Panel was used for this research study.

Click here for a summary of the results

Bob Harlow speaks at ESOMAR’s Panel Research conference

The ESOMAR conference was devoted to topics on panel quality and ran from October 21-23, 2008 in Dublin, Ireland. Bob presented a methodological case study illustrating differences in data quality resulting from different online panel recruitment methods. The case study compared survey data from two B2B IT decision maker online panels to each other and to data collected from a phone-to-Web sample. One of the online panels was RONIN’s IT decision maker panel that, although an online panel, was recruited by telephone using the probabilistic sampling seen in high-quality telephone recruit studies. The other was an externally-procured panel developed via targeted solicitations to B2B Web sites (similar to the non-probability sampling most seen in use today). Many of the data quality problems attributed to online panels (such as "straightlining" or "flatlining") were markedly reduced in RONIN’s online panel, and data from that panel were more robust in statistical analyses. This case study illustrates these differences, and presents guidelines for building panels that produce high quality data.

Click here to of this paper.

Quantitative Naming, Value Proposition and Message Testing Methodology developed

RONIN has released its quantitative Naming, Value Proposition and Message Testing methodology, designed for rapid implementation, low cost, and speedy reporting. Designed as a SaaS application, and based on RONIN’s panel, it is an approach that eases comparisons by segment, such as respondent type and country, and employs consistent measures for assessing message effectiveness. Recently used on a multi-country study with 29 messages, the entire study was implemented and reported in less than 8 weeks.

Click here on this methodology.

RONIN quality reaffirmed through two ISO certifications

RONIN's commitment to quality in all aspects of its operation has been reaffirmed in its ISO certification following audits in late 2009. By being ISO registered, RONIN has demonstrated that its systems and processes comply with pertinent ISO standards and has been successfully assessed by the independent audit body, MQA (Marketing Quality Assurance, LLC).

Two certifications were awarded: ISO 20252:2006 and ISO 9001:2008. RONIN’s global panels of Medical Specialists and IT Decision-Makers were included in the certifications.

ISO 20252:2006 is a standard designed to set a common level of quality for market research globally. This standard establishes the terms and definitions, as well as the service requirements for organizations and professionals conducting marketing, opinion and social research. RONIN was the second company worldwide to be certified by ISO 20252:2006.

ISO9001:2008 is a quality systems standard that is applicable to all industries worldwide. The standard addresses products and services and the processes that are used to create them. It emphasizes principles, goals and objectives and focuses on helping companies meet customer requirements and expectations. 2008 is the newest form of this standard which not all companies have achieved.

For both certifications, RONIN is audited annually and must demonstrate that quality systems and processes are in place and that they are incorporated into the operation of the company.